Eye Care News: Recent News in Eye care
Eye care News Feed
- Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved patient outcomes.
- Advanz Pharma and Alvotech announced AVT06, a biosimilar to Eylea, was approved for neovascular age-related macular degeneration
- NCX 470 met the primary endpoint of non-inferiority in lowering intraocular pressure (IOP) from baseline compared to the standard of care, latanoprost 0.005%.
- Included is the supplemental Biologics License Application (sBLA) for EYLEA HD seeking approval for both the treatment of macular edema following retinal vein occlusion (RVO) and the broadening of the dosing schedule to include every 4-week dosing across approved indications.
- VivaVision Biotech welcomes renowned ophthalmologist Quan Dong Nguyen to its scientific advisory board with hopes of boosting innovation in ocular disease therapies.
- Advances address a need for the growing populace with age-related near vision loss.
- Dan Ignaszewski explains how the national advocacy campaign aims to unite patients, researchers, and clinicians to protect NEI’s independence and ensure vision research funding.
- Annexin Pharmaceuticals initiates a Phase 2a study for ANXV in diabetic retinopathy to explore new treatment options and improve patient outcomes.
- The company previously provided an update in April 2025 stating its intention to lay off approximately 65% of the company after the COAST trial failed to meet its primary end point.
- Best disease, or vitelliform macular dystrophy, is a rare, inherited retinal condition causing macular degeneration by mutations in the BEST1 gene, leading to progressive vision loss and, in some cases, blindness.
- Fovea-sparing, multifocal, and bilateral lesions exhibited the fastest growth rates.
- Omer Trivizki discusses promising results of VOY-101, a gene therapy for geographic atrophy, highlighting safety and next steps in ongoing research.
- jCyte initiates patient dosing in a new trial for famzeretcel, aiming to transform treatment options for retinitis pigmentosa.
- Extend the summer at EyeCon 2025—where clinical insight meets coastal vibes—September 26 and 27 at the Margaritaville Hollywood Beach Resort in Florida.
- The two aim to develop a potential first-in-class melanocortin receptor-targeted treatment for patients with retinal diseases.
- RAMQ is a public organization introduced in 1970, following the adoption of the universal health care system in Canada.
- Maturing of the vestibulo-ocular reflex is independent of sensory input
- Inspired by cyanotype photography and his first trip to Japan in the summer, Gustavo Assis, creative director at LAPIMA, puts a sky blue lens, neither too cold nor too warm, […] This story LAPIMA Perfect Blue – appears on The Optical Journal.
- The global optical industry is gearing up for one of the most anticipated events of the year, VisionPlus EXPO, 2025, returning to the Dubai World Trade Centre on November 17–18, […] This story Explore New Technologies At VisionPlus EXPO – appears on The Optical Journal.
- Paris — the city of aesthetics, elegance, and light — became the setting for ILHEMENT’s new loungewear collection. Born in Zurich, ILHEMENT transforms tailored tradition into bold modernity: wide silhouettes, […] This story NIRVAN JAVAN On Set With ILHEMENT – appears on The Optical Journal.
- INVU launches its latest innovation just in time for SILMO: a stylish optical collection featuring ultra-polarized magnetic sun clips that transform prescription eyewear into fashionable sunglasses in seconds. Each clip […] This story INVU Unveils the New Optical Frame + Clip Collection – appears on The Optical Journal.
- The International Agency for the Prevention of Blindness (IAPB) has launched the highly anticipated World Sight Day 2025 Photo Competition. Since its inception in 2015, the IAPB World Sight Day […] This story IAPB’s World Sight Day Photo Competition Marks 10 Years – appears on The Optical Journal.
- John Seegers of Optician Works and Laramy-K, have graciously shared some of their awesome videos with us to share with you. John is one of the best trainers of opticians and his […] This story Teachable Tuesday – Optician Training – The Boxing System – appears on The Optical Journal.
- LKC Technologies, a leader in functional testing using electroretinography (ERG), announces results of a longitudinal prospective study, which found that ERG/pupillometry outperforms structural imaging in identifying patients at highest risk […] This story Study Identifies RETeval DR Score As Predictor Of Diabetic Retinopathy Progression – appears on The Optical Journal.
- We all know the old wedding rhyme: “Something old, something new, something borrowed, something blue.” Though often shortened today, it traditionally ends with, “and a sixpence in your shoe.” As […] This story Something Old, Something New… A Trade Show Tale – appears on The Optical Journal.
- Sunday Somewhere is more than a brand; it’s a state of mind. A quiet invitation to reflect, to discover, and to see the world with intention. Every frame tells a […] This story New Sunday Somewhere Optical Styles – appears on The Optical Journal.
- Ultra Limited returns to SILMO Paris with a new creative direction that places lightness at the centre of its design language. The new optical collection explores this concept in every […] This story Ultra Limited To Present New Designs At SILMO – appears on The Optical Journal.
- Researchers found that patients with primary open-angle glaucoma have less agmatine and thiamine in the aqueous humor in comparison to patients without glaucoma.
- Researchers used adaptive optics scanning light ophthalmoscopy (AOSLO) to study retinas in mice with photoreceptor damage, specifically photoreceptor laser injury.
- Nutrition is not ancillary to eye health—it is foundational.
- Research reveals that increased exposure to green spaces significantly reduces the risk of developing dry eye disease, highlighting urban planning's vital role in public health.
- Now, PECAA Max members will have access to ABB’s independent lab network and comprehensive portfolio of premium and proprietary lenses.
- The study included the screening of 9857 drivers in 8 Indian states at automative shops and transit hubs.
- Specifically, the study found that the muscle that controls eyelid movement, or the orbicularis oculi, “contracts in complex patterns that vary by action and move the eyelid in more than just a simple up-and-down motion."
- The campaign provides Generation Z insights, comprehensive practice resources, and PRECISION contact lens portfolio rebates.
- A few tweaks to outdoor exercise routines can bring great relief.
- Catch up on the top stories in optometry during the week of August 11-August 15.
- Allen, OD, FAAO, Dipl ABO, plans to talk all things ocular surface for optometrists and ophthalmologists alike.
- The committee will work to help the organization increase awareness and early identification of diabetes-related eye diseases, improve access to eye care treatment, policy development, research, and surveillance.
- The study explored the use of DMSt, used in OptiLIFT, in enhancing eyelid muscle function, improving blink dynamics, and consequently alleviating dry eye symptoms.
- With this expansion, BostonSight reinforces its commitment to advancing care for patients with severe ocular surface disease and irregular corneas.
Follow us in Facebook
You must be logged in to post a comment.